Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,264.00    32.00 (2.60%)
Bid:
1,256.00
Ask:
1,266.00
Spread: 10.00 (0.796%)
Market Cap: £245.21m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Investor Webinar

2 Mar 2026 07:00

The Biotech Growth Trust PLC - Investor Webinar

The Biotech Growth Trust PLC - Investor Webinar

PR Newswire

LONDON, United Kingdom, March 02

For immediate re lease

2 March 2026

THE BIOTECH GROWTH TRUST PLC

(the "Company")

Investor Webinar: Wednesday, 11 March, 3pm GMT (1 hour duration)

 

The Company is pleased to announce that portfolio managers, Geoff Hsu and Josh Golomb, will be providing an update on the Company, including investment performance and portfolio positioning for 2026 and beyond, on Wednesday 11 March 2026 at 3pm UK time.  

The rate - cutting cycle, fading concerns about the political environment, robust opportunities for M&A, and ongoing innovation in the sector have all provided a tailwind for biotech. As biotech valuations continue to recover from historical lows, the outlook for the sector and The Biotech Growth Trust appears compelling.

The webinar is open to all professional existing and prospective shareholders. Registration is free and a certificate of attendance can be provided if appropriate. The webinar will also be made available on the Frostrow Capital YouTube page http://www.youtube.com/@frostrowcapital7463 .

Those interested should contact Frostrow Investor Relations to register:   ir@frostrow.com

 

For and on behalf of

Frostrow Capital LLP

Company Secretary

 

For further information, please contact:

Frostrow Investor Relations: ir@frostrow.com

 



Date   Source Headline
12th Jun 20251:17 pmPRNNet Asset Value(s)
11th Jun 20253:08 pmPRNNet Asset Value(s)
11th Jun 20252:20 pmPRNDirector/PDMR Shareholding
10th Jun 202512:40 pmPRNNet Asset Value(s)
9th Jun 20251:54 pmPRNNet Asset Value(s)
6th Jun 20255:31 pmPRNTransaction in Own Shares
6th Jun 20253:07 pmPRNNet Asset Value(s)
5th Jun 20251:20 pmPRNNet Asset Value(s)
4th Jun 20252:19 pmPRNDirector/PDMR Shareholding
4th Jun 202512:49 pmPRNNet Asset Value(s)
4th Jun 20257:00 amPRNAnnual Financial Report
3rd Jun 20251:50 pmPRNNet Asset Value(s)
2nd Jun 20252:13 pmPRNNet Asset Value(s)
2nd Jun 202511:37 amPRNTotal Voting Rights
30th May 20253:16 pmPRNNet Asset Value(s)
29th May 20252:04 pmPRNNet Asset Value(s)
28th May 20251:51 pmPRNNet Asset Value(s)
27th May 20253:40 pmPRNNet Asset Value(s)
23rd May 20255:50 pmPRNTransaction in Own Shares
23rd May 20252:36 pmPRNNet Asset Value(s)
22nd May 20253:16 pmPRNNet Asset Value(s)
21st May 20251:15 pmPRNNet Asset Value(s)
20th May 20251:41 pmPRNNet Asset Value(s)
19th May 20252:17 pmPRNNet Asset Value(s)
16th May 20255:25 pmPRNTransaction in Own Shares
16th May 20252:42 pmPRNNet Asset Value(s)
16th May 202512:37 pmPRNMonthly Fact Sheet as at 30 April 2025
15th May 20251:02 pmPRNNet Asset Value(s)
14th May 20252:30 pmPRNNet Asset Value(s)
13th May 20251:48 pmPRNNet Asset Value(s)
12th May 20251:11 pmPRNNet Asset Value(s)
9th May 20255:18 pmPRNTransaction in Own Shares
9th May 20252:16 pmPRNNet Asset Value(s)
8th May 20251:46 pmPRNNet Asset Value(s)
7th May 20251:59 pmPRNNet Asset Value(s)
7th May 20251:36 pmPRNHolding(s) in Company
6th May 20252:20 pmPRNNet Asset Value(s)
2nd May 20255:15 pmPRNCompliance with Market Abuse Regulation
2nd May 20255:13 pmPRNTransaction in Own Shares
2nd May 20251:59 pmPRNNet Asset Value(s)
1st May 20251:54 pmPRNNet Asset Value(s)
1st May 20259:58 amPRNTotal Voting Rights
30th Apr 202511:35 amPRNNet Asset Value(s)
29th Apr 20252:16 pmPRNNet Asset Value(s)
28th Apr 20253:13 pmPRNNet Asset Value(s)
25th Apr 20255:10 pmPRNTransaction in Own Shares
25th Apr 20252:32 pmPRNNet Asset Value(s)
24th Apr 20251:29 pmPRNNet Asset Value(s)
23rd Apr 20252:43 pmPRNNet Asset Value(s)
22nd Apr 20251:08 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.